Pentoxifylline attenuates the increase in whole blood viscosity after transfusion

Acta Anaesthesiologica Scandinavica

Volumn 49, Issue 1, 2005, Pages 41-46

  Bacher, Andreas ^a   Eggensperger, E ^a   Koppensteiner, R ^b   Mayer, N ^a   Klimscha, W ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Anaemia; Pentoxifylline; Red packed blood cells; Rheology; Transfusion; Viscosity

Indexed keywords

PENTOXIFYLLINE; PLACEBO;

ADULT; AGED; ARTICLE; BLOOD RHEOLOGY; BLOOD VISCOSITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; ERYTHROCYTE TRANSFUSION; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMATOCRIT; HEMORRHAGIC SHOCK; HUMAN; INTERMITTENT CLAUDICATION; MALE; PLASMA VISCOSITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHEAR RATE; TISSUE OXYGENATION;

ADULT; AGED; BLOOD TRANSFUSION; BLOOD VISCOSITY; CRITICAL ILLNESS; FEMALE; HEMATOCRIT; HUMANS; MALE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; PENTOXIFYLLINE; PLASMA; RESPIRATION, ARTIFICIAL; VASODILATOR AGENTS;

EID: 13444250074     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2004.00547.x     Document Type: Article

References (24)

1. Nicolaides AN, Horbourne T, Bowers R, Kidner PH, Besterman EM. Blood viscosity, red-cell flexibility, haematocrit, and plasma-fibrinogen in patients with angina. Lancet 1977; 2: 943-5.
2. Jan KM, Heldman J, Chien S. Coronary hemodynamics and oxygen utilization after hematocrit variations in hemorrhage. Am J Physiol 1980; 239: H326-32.
3. Schneditz D, Rainer F, Kenner T. Viscoelastic properties of whole blood. Influence of fast sedimenting red blood cell aggregates. Biorheology 1987; 24: 13-22.
4. Wells RE Jr, Gawronski TH, Cox PJ, Perera RD. Influence of fibrinogen on flow properties of erythrocyte suspensions. Am J Physiol 1964; 207: 1035-40.
5. Tanahashi N, Gotoh F, Tomita M et al. Enhanced erythrocyte aggregability in occlusive cerebrovascular disease. Stroke 1989; 20: 1202-7.
6. Chmiel H, Anadere I, Heimburg P. The influence of I.V. application of pentoxifylline on the viscoelasticity of blood in patients with peripheral vascular disorders. Ric Clin Lab 1981; 11 (Suppl. 1): 189-96.
7. Johnsson R. Effect of pentoxifylline on red cell flexibility and cation transport in healthy subjects and patients with hereditary spherocytosis. Scand J Haematol 1979; 23: 81-7.
8. Johnsson R, Harjola PT, Siltanen P. Effect of pentoxifylline on red cell flexibility in arterio-sclerotic patients and in patients with heart valve prosthesis. Scand J Clin Lab Invest Suppl 1981; 156: 297-300.
9. Voisin L, Breuille D, Ruot B et al. Cytokine modulation by PX differently affects specific acute phase proteins during sepsis in rats. Am J Physiol 1998; 275: R1412-9.
10. Perhoniemi V, Salmenkivi K, Sundberg S, Johnsson R, Gordin A. Effects of flunarizine and pentoxifylline on walking distance and blood rheology in claudication. Angiology 1984; 35: 366-72.
11. Strano A, Davi G, Avellone G, Novo S, Pinto A. Double blind, crossover study of the clinical efficacy and the hemorheological effects of pentoxifylline in patients with occlusive arterial disease of the lower limbs. Angiology 1984; 35: 459-66.
12. Porter JM, Cutler BS, Lee BY, Reich T, Reichle FA, Scogin JT, Strandness DE. Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients. Am Heart J 1982; 104: 66-72.
13. Bacher A, Mayer N, Klimscha W, Oismuller C, Steltzer H, Hammerle A. Effects of pentoxifylline on hemodynamics and oxygenation in septic and nonseptic patients. Crit Care Med 1997; 25: 795-800.
14. Chohan SS, McArdle F, McClelland DB, Mackenzie SJ, Walsh TS. Red cell transfusion practice following the transfusion requirements in critical care (TRICC) study: prospective observational cohort study in a large UK intensive care unit. Vox Sang 2003; 84: 211-8.
15. Dawson DL, Zheng Q, Worthy SA, Charles B, Bradley DV Jr. Failure of pentoxifylline or cilostazol to improve blood and plasma viscosity, fibrinogen, and erythrocyte deformability in claudication. Angiology 2002; 53: 509-20.
16. Cloutier G, Qin Z, Durand LG, Teh BG. Power Doppler ultrasound evaluation of the shear rate and shear stress dependences of red blood cell aggregation. IEEE Trans Biomed Eng 1996; 43: 441-50.
17. Otto C, Richter WO, Schwandt P. Contribution of fibrinogen and lipoproteins to plasma viscosity in hypercholesterolemia and hypertriglyceridemia: evaluation by selective depletion of low-density lipoproteins or fibrinogen. Metabolism 2000; 49: 810-3.
18. Albornoz LE, Sanchez SB, Bandi JC, Canteros G, de las Heras M, Mastai RC. Pentoxifylline reduces nephrotoxicity associated with cyclosporine in the rat by its rheological properties. Transplantation 1997; 64: 1404-7.
19. Schubotz R, Muhlfellner O. The effect of pentoxifylline on erythrocyte deformability and on phosphatide fatty acid distribution in the erythrocyte membrane. Curr Med Res Opin 1977; 4: 609-17.
20. Hovav T, Yedgar S, Manny N, Barshtein G. Alteration of red cell aggregability and shape during blood storage. Transfusion 1999; 39: 277-81.
21. Nagaprasad V, Singh M. Sequential analysis of the influence of blood storage on aggregation, deformability and shape parameters of erythrocytes. Clin Hemorheol Microcirc 1998; 18: 273-84.
22. Kirkpatrick UJ, Adams RA, Lardi A, McCollum CN. Rheological properties and function of blood cells in stored bank blood and salvaged blood. Br J Haematol 1998; 101: 364-8.
23. Kirschenbaum LA, Aziz M, Astiz ME, Saha DC, Rackow EC. Influence of rheologic changes and platelet-neutrophil interactions on cell filtration in sepsis. Am J Respir 2000; 161: 1602-7.
24. Astiz ME, DeGent GE, Lin RY, Rackow EC. Microvascular function and rheologic changes in hyperdynamic sepsis. Crit Care Med 1995; 23: 265-71.